Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Outlook Therapeutics, Inc. - Common Stock
(NQ:
OTLK
)
0.4002
+0.0903 (+29.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Outlook Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Nasdaq Surges 100 Points; Dollar General Earnings Beat Views
↗
August 28, 2025
Via
Benzinga
Topics
Earnings
Let's take a look at the stocks that are in motion in today's session.
↗
August 28, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
FDA Rejects Outlook Therapeutics Eye Drug For Second Time
↗
August 28, 2025
Outlook Therapeutics shares fall after the FDA rejects its ONS-5010 wet AMD drug application, citing insufficient efficacy evidence despite prior trial success.
Via
Benzinga
The market is filled with gapping stocks in Thursday's session.
↗
August 28, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Outlook Therapeutics Stock Nose-Dives 66% In Pre-Market – Here’s Why
↗
August 28, 2025
Via
Stocktwits
Top 3 Health Care Stocks That Could Blast Off This Month
↗
January 06, 2025
Via
Benzinga
US Stocks Mixed; Nvidia Posts Upbeat Earnings
↗
August 28, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
August 28, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 28, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 27, 2025
Via
Benzinga
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
↗
August 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 26, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
August 18, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Outlook Therapeutics Reports Q3 Revenue
↗
August 14, 2025
Via
The Motley Fool
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
July 22, 2025
Via
ACCESS Newswire
Rubrik To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
↗
June 06, 2025
Via
Benzinga
Discover the top movers in Friday's pre-market session.
↗
May 23, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
June 04, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:OTLK),(NASDAQ:EYEN),(NYSE:BLCO),(NASDAQ:BMEA) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 22, 2025
Via
Benzinga
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
June 04, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Thursday's after hours session: top gainers and losers
↗
May 22, 2025
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
February 18, 2025
Via
Benzinga
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
↗
January 16, 2025
Outlook Therapeutics plans to resubmit ONS-5010 for FDA approval in 2025 following NORSE EIGHT trial results in wet AMD patients.
Via
Benzinga
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
↗
December 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 27, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; HP Shares Plunge
↗
November 27, 2024
Via
Benzinga
Dow Falls Over 100 Points; US Crude Oil Stocks Decline
↗
November 27, 2024
Via
Benzinga
Topics
Stocks
US Stocks Mixed; Economy Grows By 2.8% In Q3
↗
November 27, 2024
Via
Benzinga
Topics
Economy
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
↗
November 27, 2024
Outlook Therapeutics reports ONS-5010 missed noninferiority endpoint in NORSE EIGHT trial for wet AMD but showed vision improvement and safety profile.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
